Absent much drama, Wednesday's National Signing Day was a celebration of the work programs have done to assemble top-ranked classes. The Early Signing Period's Wednesday start (Dec. 3-5) formally ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Classes are one of the many reasons why 99 Nights in the Forest has so much replayability. Each class has its own set of starter tools to change your gameplay, as well as level upgrades that will give ...

Years of rising costs for necessities like housing, transportation and healthcare are causing many Americans to feel like financial comfort — once a feature of middle-class life — is getting further ...

VALHALLA, N.Y.--(BUSINESS WIRE)--Rectangle Health, the leader in patient engagement, payments, and office compliance solutions for healthcare providers, today announced the launch of its unified ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

Salt Lake City, UT, July 08, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...